DG 041

Drug Profile

DG 041

Alternative Names: D 151746; DG-041

Latest Information Update: 14 Jan 2011

Price : *
* Final gross price and currency may vary according to local VAT and billing address.

At a glance

  • Originator deCODE genetics
  • Class Small molecules; Sulfonamides; Thiophenes
  • Mechanism of Action Dinoprostone receptor antagonists
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

  • Available For Licensing Yes

Highest Development Phases

  • Suspended Peripheral arterial occlusive disorders

Most Recent Events

  • 13 Jan 2011 Suspended - Phase-II for Peripheral arterial occlusive disorders in Europe (PO)
  • 30 Jun 2008 DG 041 is available for licensing (http://www.decode.com)
  • 30 Jun 2008 deCODE genetics completes a clinical pharmacology trial of DG 041 in combination with aspirin and clopidogrel
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top